Two Sigma Investments »

Achilles Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $70k 62k 1.14
2024-09-30 $22k 21k 1.02
2024-06-30 $18k 22k 0.82
2024-03-31 $15k 12k 1.25

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Achilles Therapeutics

Rhumbline Advisers
GAMMA Investing

View all funds holding Achilles Therapeutics